364794-82-1 Usage
Uses
Used in Organic Synthesis:
4-(3-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure and reactivity make it a valuable component in the synthesis of complex molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-(3-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine is used as a research tool to explore its potential as a precursor for the development of new drugs. Its specific properties may contribute to the discovery of novel therapeutic agents.
Used in Medicinal Chemistry:
4-(3-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine is employed in medicinal chemistry as a building block for the design and synthesis of bioactive molecules. Its incorporation into drug candidates may enhance their pharmacological properties, such as potency, selectivity, and bioavailability.
Used in Drug Development:
In the field of drug development, 4-(3-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine is used as a key component in the creation of new pharmaceuticals. Its unique structural features and reactivity may contribute to the development of innovative treatments for various diseases and medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 364794-82-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,4,7,9 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 364794-82:
(8*3)+(7*6)+(6*4)+(5*7)+(4*9)+(3*4)+(2*8)+(1*2)=191
191 % 10 = 1
So 364794-82-1 is a valid CAS Registry Number.
364794-82-1Relevant articles and documents
Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors
Berger, Dan,Dutia, Minu,Powell, Dennis,Wissner, Allan,DeMorin, Frenel,Raifeld, Yuri,Weber, Jennifer,Boschelli, Frank
, p. 2989 - 2992 (2007/10/03)
A series of substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles has been prepared as Src kinase inhibitors. Optimal activity is observed with compounds that have basic amines attached via the para position of the 7-phenyl ring, and a hydrogen atom at the C-6 position. The best compounds are low nanomolar inhibitors of Src kinase, and have potent activity against Src-transformed fibroblast cells.